Abstract:It is thought that ablative radiotherapy (RT), used for rapid control tumor growth, induces genotoxic stress and mitosis crisis leading to prolonged dormancy of irradiated tumor at local and distal site in most patients. We have unexpectedly observed that initial reduction of tumor burden following ablative RT also depends largely on type I IFN for CTL. Targeting tumor with IFN can control tumor growth through initiating a coordinated innate and adaptive immune attack against tumor cells. However, the mechanism for radiation-mediated type I IFN induction remains unclear. Here, we demonstrated that STING, but not MYD88, was required for type I IFN-dependent antitumor effects of radiation. STING in dendritic cells (DCs) controlled radiation-mediated IFN-β induction and was activated by irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP synthase (cGAS) mediated DCs sensing of irradiated-tumor cells. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-β treatment rescued cGAS/STING-deficient immune responses. Accordingly, enhancing STING signaling by cGAMP administration promoted antitumor efficacy of radiation. Our results reveal that the molecular mechanism of radiation-mediated antitumor immunity depends on a proper cytosolic DNA-sensing pathway, pointing towards a new understanding of radiation and host interactions. Furthermore, we uncover a new strategy to improve radiotherapy by cGAMP treatment. RT induced IFN can also upregulate PD-L1 that suppress T cell-mediated damage and develop radiation resistance for relapse over time. Anti-PDL-1 antibody can greatly reduce radiation resistance leading to complete tumor regression. Furthermore, our study challenges the rationale for current radio/chemotherapy strategies and highlights the importance of immune activation in preventing tumor relapse. Citation Format: Yang-xin Fu. Radiation-mediated DNA sensing pathway for immunity and tumor regression. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr SY39-03. doi:10.1158/1538-7445.AM2015-SY39-03

Irradiated Tumour Cell-Derived Microparticles Upregulate MHC-I Expression in Cancer Cells Via DNA Double-Strand Break Repair Pathway

Irradiated Engineered Tumor Cell-Derived Microparticles Remodel the Tumor Immune Microenvironment and Enhance Antitumor Immunity.

Irradiated tumor cell-derived microparticles mediate tumor eradication via cell killing and immune reprogramming

Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice

Ionizing Radiation Triggers Mitophagy to Enhance DNA Damage in Cancer Cells.

Radiation-Mediated Dna Sensing Pathway For Immunity And Tumor Regression

Ataxia telangiectasia mutated kinase inhibition promotes irradiation-induced PD-L1 expression in tumour-associated macrophages through IFN-I/JAK signalling pathway

Triple Kill: DDR Inhibitors, Radiotherapy and Immunotherapy Leave Cancer Cells with No Escape

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

Irradiation and Anti-Pd-l1 Treatment Synergistically Promote Antitumor Immunity in Mice.

ATM Expression is Elevated in Established Radiation-Resistant Breast Cancer Cells and Improves DNA Repair Efficiency

Irradiated tumor cell-released microparticles enhance the therapeutic efficacy of PD-1 inhibitors by promoting M1-TAMs polarization in NSCLC brain metastases

Mechanism of immune activation mediated by genomic instability and its implication in radiotherapy combined with immune checkpoint inhibitors

Harnessing The Targeting Potential Of Differential Radiobiological Effects Of Photon Versus Particle Radiation For Cancer Treatment

ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I

Administration of MIP-3alpha Gene to the Tumor Following Radiation Therapy Boosts Anti-Tumor Immunity in a Murine Model of Lung Carcinoma.

Downregulation of MDC1 and 53BP1 by Short Hairpin RNA Enhances Radiosensitivity in Laryngeal Carcinoma Cells.

Radiotherapy Upregulates Programmed Death Ligand-1 Through the Pathways Downstream of Epidermal Growth Factor Receptor in Glioma.

DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer

Irradiation Suppresses IFNγ-Mediated PD-L1 and MCL1 Expression in EGFR-Positive Lung Cancer to Augment CD8+ T Cells Cytotoxicity

Radiotherapy activates autophagy to increase CD8 + T cell infiltration by modulating major histocompatibility complex class-I expression in non-small cell lung cancer.